Evaluation of Technetium-99m Red Blood Cell Labeling Efficiency in Adults Receiving Chemotherapy and the Clinical Impact on Pediatric Oncology Patients

摘要

>Objective: Technetium-99m-labeled RBCs are used to evaluate ventricular function and are the preferred method for monitoring the cardiac function of patients receiving chemotherapy. Optimal imaging quality is critical for monitoring small but important changes in ventricular function. The labeling efficiency of three products from two manufacturers and images from 30 patients (21 men, 9 women; age 60.3 ?± 11.9 yr) referred for clinical radionuclide ventriculograms before chemotherapy were evaluated to determine the best labeling technique.